BRCA 1/2 Ashkenazi Founder Mutation Panel
Test Catalog Information
| Test Catalog Synonyms | |
| EPIC Synonyms | |
| Cerner Primary Mnemonic | BRCA 1/2 Ashkenazi Founder Mutation Panel |
| EPIC Display Name | BRCA 1/2 Ashkenazi Founder Mutation Panel |
| Allscripts (AEHR) Order Name | BRCA 1/2 Ashkenazi Founder Mutation Pane |
| Sunrise Clinical Manager (SCM) Order Name | Not Orderable |
| EPIC Inpatient Orderable | No |
| EPIC Outpatient Orderable | No |
| Cerner Results |
BRCA AJ Mutation Panel |
| Clinical Info |
Discontinued 3/18/24Per NCCN guidelines, any woman of Ashkenazi Jewish ancestry who has been diagnosed with breast or ovarian cancer meets criteria for BRCA founder variant testing. Verification of a genetic basis for cancer in families indicative or suggestive of hereditary breast and ovarian cancer. Determination of appropriate screening and treatment. Identification of at-risk family members. |
| Specimen Type |
Blood |
| Container |
Lavender Top Tube |
| Collection Instructions |
Container/Tube: Lavender top tube(s) Specimen: 3 - 5 mL Whole Blood Transport Temperature: Room Temperature Note: Requires Ethnicity (required for interpretation) Choices are: Northern European (British, German) Southern European (Italian, Greek) French Canadian Ashkenazi Jewish Finnish Other/Mixed Caucasian East Asian (Chinese, Japanese) South Asian (Indian, Pakistani) Southeast Asian (Filipino, Vietnamese) African or African American Hispanic Middle Eastern Native American Pacific Islander Unknown |
| Transport Instructions |
Room Temperature |
| Specimen Stability |
7 Days RefrigeratedBlood samples older than 7 days can still be shipped, they will be tested if the yield and quality of DNA permit. |
| Methodology |
Capillary Sequencing |
| Days Performed | |
| Performing Laboratory |
BioReference Laboratories |
| CPT |
81212 Turnaround Time: 8-10 days |
| PDM |
1659840 |
Desired Epic Build BRCA 1/2 Ashkenazi Founder Mutation Panel
| Cerner Primary Mnemonic: | BRCA 1/2 Ashkenazi Founder Mutation Panel | ||||||
| PDM | 1659840 | ||||||
| Informatics - Workgroup | Molecular-send outs | ||||||
| Synonyms * | |||||||
| Display Name * | BRCA 1/2 Ashkenazi Founder Mutation Panel | ||||||
| Order Entry Specimen Sources * | |||||||
| Order Entry Specimen Types |
Blood
| ||||||
| Specimen Navigator Specimen Types | |||||||
| Specimen Navigator Specimen Sources | |||||||
| Specimen Navigator Short Name | |||||||
| Ordering info (EPIC SmartText) | Discontinued 3/18/24Per NCCN guidelines, any woman of Ashkenazi Jewish ancestry who has been diagnosed with breast or ovarian cancer meets criteria for BRCA founder variant testing. Verification of a genetic basis for cancer in families indicative or suggestive of hereditary breast and ovarian cancer. Determination of appropriate screening and treatment. Identification of at-risk family members. | ||||||
| IP Orderable | No | ||||||
| OP Orderable | No | ||||||
|
AOEs * | |||||||
| AP AOEs | |||||||
| Special History | No | ||||||
| Build Comments | |||||||
| Filter * | genetics | ||||||
| Procedure Category Change | |||||||
Cerner Results
| |||||||
Actual Epic build
| Procedure Id | 115519 | ||||||||||||
| Pdm | 1659840 | ||||||||||||
| Order Display Name | BRCA 1/2 Ashkenazi Founder Mutation Panel | ||||||||||||
| Procedure Name | BRCA 1/2 ASHKENAZI FOUNDER MUTATION PANEL | ||||||||||||
| Procedure Master Number | LAB11602 | ||||||||||||
| Short Procedure Name | BRCA 1/2 ASHKENAZI FOUNDER MUTATION PANEL | ||||||||||||
| Category Code | 15.0 | ||||||||||||
| Category Code Record Name | LAB CYTOGENETICS ORDERABLES | ||||||||||||
| Synonyms | |||||||||||||
| Clinically Active | No | ||||||||||||
| Orderable | |||||||||||||
| Performable | |||||||||||||
| Filter Genomics | Generic Genomics Procedure | ||||||||||||
| Reference Link Url | https://labs.northwell.edu/epic/test/115519 | ||||||||||||
| Ordering Instructions | |||||||||||||
| Default Specimen Type | Blood | ||||||||||||
| Specimen Type Pick List | Blood | ||||||||||||
| Specimen Type List | |||||||||||||
| Op Specimen Type List | |||||||||||||
| Specimen Source Pick List | Blood, Arterial Blood, Capillary Blood, Central Line Blood, Venous | ||||||||||||
| Specimen Source Default - Male | |||||||||||||
| Specimen Source Default - Female | |||||||||||||
| Specimen Source List | |||||||||||||
| Op Specimen Source List | |||||||||||||
| Ip Lab Test Components For Report | |||||||||||||
| Op Lab Test Components For Report | |||||||||||||
| Order Questions | ["3048500000"] | ||||||||||||
| Order Questions Record Name | |||||||||||||
| Inpatient Order Questions | ["3048500000"] | ||||||||||||
| Inpatient Order Questions Record Name | |||||||||||||
| Order Specific Question Override | |||||||||||||
| Inpatient Question Override | |||||||||||||
| Location Restrict List Ip | |||||||||||||
| Location Restrict List Ip Record Name | |||||||||||||
| Location Restrict List Include Ip | |||||||||||||
| Location Restrict List Op | |||||||||||||
| Location Restrict List Op Record Name | |||||||||||||
| Location Restrict List Includes Op | |||||||||||||
| Edp Amb Order Specific Questions Record Name | NH IP PATIENT COMPLETED CONSENT | ||||||||||||
| Edp Ip Order Specific Questions Record Name | NH IP PATIENT COMPLETED CONSENT | ||||||||||||
| Edp Ip Specimen Source | |||||||||||||
| Edp Op Specimen Source | |||||||||||||
| Edp Ip Specimen Type | |||||||||||||
| Edp Op Specimen Type | |||||||||||||
| Derived Edp Ip Buttons S | |||||||||||||
| Derived Edp Ip Buttons T | |||||||||||||
| Derived Edp Op Buttons S | |||||||||||||
| Derived Edp Op Buttons T | |||||||||||||
| Ip Orderable | 0 | ||||||||||||
| Op Orderable | 0 | ||||||||||||
EPIC OP AOEs
| |||||||||||||
EPIC IP AOEs
| |||||||||||||
EPIC Components (results)
| |||||||||||||